About
UC Drug Formulation
Areas of Focus
Categories
Drug Delivery & FormulationBoston & New England
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
2
As Collaborator
8
Total Enrollment
10,810
By Phase
NA: 6PHASE3: 1PHASE1: 1
By Status
COMPLETED: 6UNKNOWN: 2RECRUITING: 1NOT_YET_RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06506448Collaborator
Risk Characterization of Non-culprit Vessels in Patients Undergoing Primary PCI for ST-elevation MI in Multivessel Disease
N/ARecruiting
320 participants
Started: Jan 20, 2025 · Completed: Jan 31, 2029
NCT06339125Collaborator
Predictive Analytics and Computer Visualization Enhances Patient Safety to Prevent Falls
NANot yet recruiting
4,500 participants
Started: May 31, 2024 · Completed: Jul 31, 2025
NCT04469686Lead Sponsor
Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories
PHASE3Completed
200 participants
Started: Dec 10, 2020 · Completed: Sep 19, 2024
NCT05625464Collaborator
Effect of Automated Real-time Feedback on Early Sepsis Care
NACompleted
3,269 participants
Started: Dec 1, 2020 · Completed: Nov 30, 2021
NCT05876429Collaborator
Optimizing the Safety of Inter-Hospital Transfer
NAUnknown
1,188 participants
Started: Aug 17, 2020 · Completed: Jun 30, 2023
Locations (1)
Headquarters
Concord, MA, United States
Map
Loading map...